Combining Celexa and Mirtazapine in Geriatric Patients

Pharmacological Compatibility

• The American Academy of Family Physicians lists citalopram and mirtazapine as appropriate options for geriatric depression, with citalopram dosed at 10-40 mg daily and mirtazapine at 7.5-30 mg at bedtime 1, 2

Key Monitoring Requirements

Serotonin Syndrome Risk

• Monitor for serotonin syndrome when combining any serotonergic agents, watching for symptoms including agitation, confusion, tremor, hyperthermia, and autonomic instability 2

Hyponatremia Risk

• Monitor electrolytes regularly during treatment, particularly in the first few weeks, as citalopram can cause or worsen hyponatremia, particularly in elderly patients 1

Sedation and Falls

• Both medications can cause sedation, with mirtazapine being particularly sedating, and assess fall risk carefully, as sedation increases fall risk in older adults 1, 2, 3, 4, 5, 6
• Consider giving mirtazapine at bedtime to minimize daytime sedation 1, 2

Dosing Recommendations for Geriatric Patients

Citalopram

• Start at 10 mg daily, with a maximum dose of 40 mg daily, and consider dose reduction in hepatic impairment 1, 2, 7

Mirtazapine

• Start at 7.5 mg at bedtime, titrate to a maximum of 30 mg at bedtime, and consider dose reduction in renal or hepatic impairment 1, 2, 7, 8

Clinical Advantages of This Combination

• Mirtazapine promotes sleep, appetite, and weight gain, which can be beneficial in elderly patients with depression-related anorexia or insomnia 1, 2
• Citalopram is well-tolerated with fewer anticholinergic effects than older antidepressants 1, 2

Important Caveats

• Avoid this combination if the patient has severe cardiac disease with QTc prolongation, as citalopram can prolong the QT interval 1
• Use extra caution in patients with multiple comorbidities requiring polypharmacy 9
• Monitor for orthostatic hypotension, particularly with mirtazapine 7
• Reassess the need for both medications after 9 months of treatment, as prolonged combination therapy should be justified by clinical benefit 1, 2